(1R*,4R*)-N-4-(Oxetan-3-yl)cyclohexane-1,4- diamine, 1g

Di(pyridin-4-yl)amine, 95.0%, 5g

Urea [for Biochemical Research]>99.0%(N)25g

2-(2-Methylthiazol-4-yl)acetonitrile, 95.0%, 2.5g

6-(Trifluoromethyl)nicotinic Acid>98.0%(GC)1g

5,5-dimethylpiperazin-2-one, 95.0%, 5g

1-Tetrahydrofurfuryl-piperazine, 97.0%, 10g

(R)-4-((1H-indol-3-yl)methyl)oxazolidin-2-one, 98%, 250mg

Hydrogénophosphate disodique dodécahydraté, min 99%, pa, ISO, 500 g, emballage plastique.

(diazyn-1-ium-1-yl)(4-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}butyl)azanide, 50mg

Methyl 6-bromobenzo[d][1,3]dioxole-4-carboxylate, 95.0%, 250mg

N-(4-sulfanylphenyl)acetamide, 95.0%, 25g

Dichloro(N,N,N',N'-tetramethylethylenediamine)palladium(II), 95.0%, 25g